{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:53:12Z","timestamp":1794981192875,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["498383"],"award-info":[{"award-number":["498383"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Folates (Vitamin B9) are critical for normal neurodevelopment and function, with transport mediated by three major pathways: folate receptor alpha (FR\u03b1), proton-coupled folate transporter (PCFT), and reduced folate carrier (RFC). Cerebral folate uptake primarily occurs at the blood-cerebrospinal fluid barrier (BCSFB) through concerted actions of FR\u03b1 and PCFT, with impaired folate transport resulting in the neurological disorder cerebral folate deficiency (CFD). Increasing evidence suggests that disorders associated with CFD also present with neuroinflammation, oxidative stress, and mitochondrial dysfunction, however the role of brain folate deficiency in inducing these abnormalities is not well-understood. Our laboratory has identified the upregulation of RFC by nuclear respiratory factor 1 (NRF-1) at the blood\u2013brain barrier (BBB) once indirectly activated by the natural compound pyrroloquinoline quinone (PQQ). PQQ is also of interest due to its anti-inflammatory, antioxidant, and mitochondrial biogenesis effects. In this study, we examined the effects of folate deficiency and PQQ treatment on inflammatory and oxidative stress responses, and changes in mitochondrial function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Primary cultures of mouse mixed glial cells exposed to folate-deficient (FD) conditions and treated with PQQ were analyzed for changes in gene expression of the folate transporters, inflammatory markers, oxidative stress markers, and mitochondrial DNA (mtDNA) content through qPCR analysis. Changes in cellular reactive oxygen species (ROS) levels were analyzed in vitro through a DCFDA assay. Wildtype (C57BL6\/N) mice exposed to FD (0\u00a0mg\/kg folate), or control (2\u00a0mg\/kg folate) diets underwent a 10-day (20\u00a0mg\/kg\/day) PQQ treatment regimen and brain tissues were collected and analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Folate deficiency resulted in increased expression of inflammatory and oxidative stress markers in vitro and in vivo, with increased cellular ROS levels observed in mixed glial cells as well as a reduction of mitochondrial DNA (mtDNA) content observed in FD mixed glial cells. PQQ treatment was able to reverse these changes, while increasing RFC expression through activation of the PGC-1\u03b1\/NRF-1 signaling pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results demonstrate the effects of brain folate deficiency, which may contribute to the neurological deficits commonly seen in disorders of CFD. PQQ may represent a novel treatment strategy for disorders associated with CFD, as it can increase folate uptake, while in parallel reversing many abnormalities that arise with brain folate deficiency.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12987-023-00488-3","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:03:02Z","timestamp":1700438582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Protective effects of pyrroloquinoline quinone in brain folate deficiency"],"prefix":"10.1186","volume":"20","author":[{"given":"Vishal","family":"Sangha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Aboulhassane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing Rui","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Bendayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"issue":"3","key":"488_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1081\/CRP-100108171","volume":"18","author":"C Wagner","year":"2001","unstructured":"Wagner C. Biochemical role of folate in cellular metabolism. Clin Res Regul Aff. 2001;18(3):161\u201380.","journal-title":"Clin Res Regul Aff"},{"issue":"2\u20133","key":"488_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.mam.2012.07.006","volume":"34","author":"R Zhao","year":"2013","unstructured":"Zhao R, Goldman ID. Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors. Mol Aspects Med. 2013;34(2\u20133):373\u201385. https:\/\/doi.org\/10.1016\/j.mam.2012.07.006.","journal-title":"Mol Aspects Med"},{"key":"488_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0083-6729(03)01012-4","volume":"66","author":"LH Matherly","year":"2003","unstructured":"Matherly LH, Goldman ID. Membrane transport of folates. Vitam Horm. 2003;66:403\u201356.","journal-title":"Vitam Horm"},{"issue":"08","key":"488_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0083-6729(08)00405-6","volume":"79","author":"LH Matherly","year":"2008","unstructured":"Matherly LH, Hou Z. Structure and function of the reduced folate carrier: a paradigm of a major facilitator superfamily mammalian nutrient transporter. Vitam Horm. 2008;79(08):145\u201384.","journal-title":"Vitam Horm"},{"issue":"8","key":"488_CR5","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.addr.2004.01.002","volume":"56","author":"BA Kamen","year":"2004","unstructured":"Kamen BA, Smith AK. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev. 2004;56(8):1085\u201397.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"488_CR6","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/annonc\/mdv250","volume":"26","author":"JA Ledermann","year":"2015","unstructured":"Ledermann JA, Canevari S, Thigpen T. Targeting the folate receptor: Diagnostic and therapeutic approaches to personalize cancer treatments. Ann Oncol. 2015;26(10):2034\u201343. https:\/\/doi.org\/10.1093\/annonc\/mdv250.","journal-title":"Ann Oncol"},{"key":"488_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/bj20020512","volume":"367","author":"JR Whetstine","year":"2002","unstructured":"Whetstine JR, Flatley RM, Matherly LH. The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter. Biochem J. 2002;367:629\u201340.","journal-title":"Biochem J"},{"key":"488_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.copbio.2017.01.006","volume":"44","author":"PJ Stover","year":"2017","unstructured":"Stover PJ, Durga J, Field MS. Folate nutrition and blood\u2013brain barrier dysfunction. Curr Opin Biotechnol. 2017;44:146\u201352. https:\/\/doi.org\/10.1016\/j.copbio.2017.01.006.","journal-title":"Curr Opin Biotechnol"},{"issue":"7","key":"488_CR9","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1074\/jbc.M807665200","volume":"284","author":"R Zhao","year":"2009","unstructured":"Zhao R, Min SH, Wang Y, Campanella E, Low PS, Goldman ID. A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis. J Biol Chem. 2009;284(7):4267\u201374.","journal-title":"J Biol Chem"},{"key":"488_CR10","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1038\/ncomms3123","volume":"4","author":"M Grapp","year":"2013","unstructured":"Grapp M, Wrede A, Schweizer M, H\u00fcwel S, Galla HJ, Snaidero N, et al. Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. Nat Commun. 2013;4:2123.","journal-title":"Nat Commun"},{"issue":"12","key":"488_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1469-8749.2004.tb00451.x","volume":"46","author":"VT Ramaekers","year":"2004","unstructured":"Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol. 2004;46(12):843\u201351.","journal-title":"Dev Med Child Neurol"},{"issue":"19","key":"488_CR12","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1056\/NEJMoa043160","volume":"352","author":"VT Ramaekers","year":"2005","unstructured":"Ramaekers VT, Rothenberg SP, Sequeira JM, Opladen T, Blau N, Quadros EV, et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med. 2005;352(19):1985\u201391.","journal-title":"N Engl J Med"},{"issue":"3","key":"488_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajhg.2009.08.005","volume":"85","author":"R Steinfeld","year":"2009","unstructured":"Steinfeld R, Grapp M, Kraetzner R, Dreha-Kulaczewski S, Helms G, Dechent P, et al. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet. 2009;85(3):354\u201363.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"488_CR14","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/brain\/aws122","volume":"135","author":"M Grapp","year":"2012","unstructured":"Grapp M, Just IA, Linnankivi T, Wolf P, L\u00fccke T, H\u00e4usler M, et al. Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency. Brain. 2012;135(7):2022\u201331.","journal-title":"Brain"},{"issue":"4","key":"488_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1055\/s-2007-991148","volume":"38","author":"VT Ramaekers","year":"2007","unstructured":"Ramaekers VT, Sequeira JM, Artuch R, Blau N, Temudo T, Ormazabal A, et al. Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome. Neuropediatrics. 2007;38(4):179\u201383.","journal-title":"Neuropediatrics"},{"issue":"6","key":"488_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1055\/s-2008-1065354","volume":"38","author":"VT Ramaekers","year":"2007","unstructured":"Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics. 2007;38(6):276\u201381.","journal-title":"Neuropediatrics"},{"issue":"3","key":"488_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/mp.2011.175","volume":"18","author":"RE Frye","year":"2013","unstructured":"Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry. 2013;18(3):369\u201381. https:\/\/doi.org\/10.1038\/mp.2011.175.","journal-title":"Mol Psychiatry"},{"key":"488_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2016.00080","volume":"10","author":"RE Frye","year":"2016","unstructured":"Frye RE, Delhey L, Slattery J, Tippett M, Wynne R, Rose S, et al. Blocking and binding folate receptor alpha autoantibodies identify novel autism spectrum disorder subgroups. Front Neurosci. 2016;10:1\u201310.","journal-title":"Front Neurosci"},{"issue":"11","key":"488_CR19","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1021\/acs.molpharmaceut.7b00572","volume":"14","author":"C Alam","year":"2017","unstructured":"Alam C, Hoque MT, Finnell RH, Goldman ID, Bendayan R. Regulation of reduced folate carrier (RFC) by vitamin D receptor at the blood-brain barrier. Mol Pharm. 2017;14(11):3848\u201358.","journal-title":"Mol Pharm"},{"issue":"35","key":"488_CR20","doi-asserted-by":"publisher","first-page":"17531","DOI":"10.1073\/pnas.1907077116","volume":"116","author":"C Alam","year":"2019","unstructured":"Alam C, Aufreiter S, Georgiou CJ, Hoque MT, Finnell RH, O\u2019Connor DL, et al. Upregulation of reduced folate carrier by Vitamin D enhances brain folate uptake in mice lacking folate receptor alpha. Proc Natl Acad Sci U S A. 2019;116(35):17531\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"488_CR21","doi-asserted-by":"publisher","first-page":"10516","DOI":"10.1096\/fj.202000239RR","volume":"34","author":"C Alam","year":"2020","unstructured":"Alam C, Hoque MT, Sangha V, Bendayan R. Nuclear respiratory factor 1 (NRF-1) upregulates the expression and function of reduced folate carrier (RFC) at the blood-brain barrier. FASEB J. 2020;34(8):10516\u201330.","journal-title":"FASEB J"},{"issue":"5","key":"488_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.tips.2020.02.004","volume":"41","author":"C Alam","year":"2020","unstructured":"Alam C, Kondo M, O\u2019Connor DL, Bendayan R. Clinical implications of folate transport in the central nervous system. Trends Pharmacol Sci. 2020;41(5):349\u201361. https:\/\/doi.org\/10.1016\/j.tips.2020.02.004.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"488_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999;98(1):115\u201324.","journal-title":"Cell"},{"issue":"6","key":"488_CR24","first-page":"A1104","volume":"21","author":"W Chowanadisai","year":"2007","unstructured":"Chowanadisai W, Bauerly K, Tchaparian E, Rucker RB. Pyrroloquinoline quinone (PQQ) stimulates mitochondrial biogenesis. FASEB J. 2007;21(6):A1104\u2013A1104.","journal-title":"FASEB J"},{"issue":"1","key":"488_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1074\/jbc.M109.030130","volume":"285","author":"W Chowanadisai","year":"2010","unstructured":"Chowanadisai W, Bauerly KA, Tchaparian E, Wong A, Cortopassi GA, Rucker RB. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1\u03b1 expression. J Biol Chem. 2010;285(1):142\u201352. https:\/\/doi.org\/10.1074\/jbc.M109.030130.","journal-title":"J Biol Chem"},{"issue":"1","key":"488_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-022-00391-3","volume":"19","author":"V Sangha","year":"2022","unstructured":"Sangha V, Hoque MT, Henderson JT, Bendayan R. Novel localization of folate transport systems in the murine central nervous system. Fluids Barriers CNS. 2022;19(1):1\u201313. https:\/\/doi.org\/10.1186\/s12987-022-00391-3.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"488_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0006-2952(02)01453-3","volume":"65","author":"K He","year":"2003","unstructured":"He K, Nukada H, Urakami T, Murphy MP. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem Pharmacol. 2003;65(1):67\u201374.","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"488_CR28","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.jnutbio.2013.07.008","volume":"24","author":"CB Harris","year":"2013","unstructured":"Harris CB, Chowanadisai W, Mishchuk DO, Satre MA, Slupsky CM, Rucker RB. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J Nutr Biochem. 2013;24(12):2076\u201384. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.07.008.","journal-title":"J Nutr Biochem"},{"issue":"8","key":"488_CR29","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s11064-013-1068-2","volume":"38","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Ding M, Cao Z, Zhang J, Ding F, Ke K. Pyrroloquinoline quinine protects rat brain cortex against acute glutamate-induced neurotoxicity. Neurochem Res. 2013;38(8):1661\u201371.","journal-title":"Neurochem Res"},{"issue":"10","key":"488_CR30","doi-asserted-by":"publisher","first-page":"e109502","DOI":"10.1371\/journal.pone.0109502","volume":"9","author":"C Yang","year":"2014","unstructured":"Yang C, Yu L, Kong L, Ma R, Zhang J, Zhu Q, et al. Pyrroloquinoline quinone (PQQ) inhibits lipopolysaccharide induced inflammation in part via downregulated NF-kB and p38\/JNK activation in microglial and attenuates microglia activation in lipopolysaccharide treatment mice. PLoS ONE. 2014;9(10):e109502.","journal-title":"PLoS ONE"},{"issue":"4","key":"488_CR31","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1096\/fj.201600906R","volume":"31","author":"KR Jonscher","year":"2017","unstructured":"Jonscher KR, Stewart MS, Alfonso-Garcia A, DeFelice BC, Wang XX, Luo Y, et al. Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. FASEB J. 2017;31(4):1434\u201348.","journal-title":"FASEB J"},{"issue":"19","key":"488_CR32","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.3390\/molecules25194359","volume":"25","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Zhou J, Shen M, Xu H, Yu S, Cheng Q, et al. Pyrroloquinoline quinone inhibits rotenone-induced microglia inflammation by enhancing autophagy. Molecules. 2020;25(19):4359.","journal-title":"Molecules"},{"issue":"1","key":"488_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3164\/jcbn.2008005","volume":"42","author":"K Ohwada","year":"2008","unstructured":"Ohwada K, Takeda H, Yamazaki M, Isogai H, Nakano M, Shimomura M, et al. Pyrroloquinoline quinone (PQQ) prevents cognitive deficit caused by oxidative stress in rats. J Clin Biochem Nutr. 2008;42(1):29\u201334.","journal-title":"J Clin Biochem Nutr"},{"issue":"2","key":"488_CR34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.molimm.2012.11.012","volume":"54","author":"AF Kolb","year":"2013","unstructured":"Kolb AF, Petrie L. Folate deficiency enhances the inflammatory response of macrophages. Mol Immunol. 2013;54(2):164\u201372. https:\/\/doi.org\/10.1016\/j.molimm.2012.11.012.","journal-title":"Mol Immunol"},{"issue":"8","key":"488_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0753-3322(01)00095-6","volume":"55","author":"CL Chern","year":"2001","unstructured":"Chern CL, Huang RFS, Chen YH, Cheng JT, Liu TZ. Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-\u03baB in human Hep G2 cells. Biomed Pharmacother. 2001;55(8):434\u201342.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"488_CR36","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1093\/jn\/137.9.2036","volume":"137","author":"YF Chou","year":"2007","unstructured":"Chou YF, Yu CC, Huang RFS. Changes in mitochondrial DNA deletion, content, and biogenesis in folate-deficient tissues of young rats depend on mitochondrial folate and oxidative DNA injuries. J Nutr. 2007;137(9):2036\u201342.","journal-title":"J Nutr"},{"issue":"7","key":"488_CR37","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1111\/jcmm.14368","volume":"23","author":"M Cheng","year":"2019","unstructured":"Cheng M, Yang L, Dong Z, Wang M, Sun Y, Liu H, et al. Folic acid deficiency enhanced microglial immune response via the Notch1\/nuclear factor kappa B p65 pathway in hippocampus following rat brain I\/R injury and BV2 cells. J Cell Mol Med. 2019;23(7):4795\u2013807.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"488_CR38","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1017\/S0007114507666410","volume":"97","author":"CM Chang","year":"2007","unstructured":"Chang CM, Yu CC, Te LuH, Chou YF, Huang RFS. Folate deprivation promotes mitochondrial oxidative decay: DNA large deletions, cytochrome c oxidase dysfunction, membrane depolarization and superoxide overproduction in rat liver. Br J Nutr. 2007;97(5):855\u201363.","journal-title":"Br J Nutr"},{"issue":"5 PART 2","key":"488_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1203\/PDR.0b013e318212f16b","volume":"69","author":"RE Frye","year":"2011","unstructured":"Frye RE, Rossignol DA. Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res. 2011;69(5 PART 2):41\u20137.","journal-title":"Pediatr Res"},{"issue":"4","key":"488_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/mp.2011.165","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2012;17(4):389\u2013401.","journal-title":"Mol Psychiatry"},{"key":"488_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2202-11-53","volume":"11","author":"JH Gibson","year":"2010","unstructured":"Gibson JH, Slobedman B, Harikrishnan KN, Williamson SL, Minchenko D, El-Osta A, et al. Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain. BMC Neurosci. 2010;11:1\u201316.","journal-title":"BMC Neurosci"},{"issue":"3","key":"488_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.spen.2013.10.008","volume":"20","author":"A Legido","year":"2013","unstructured":"Legido A, Jethva R, Goldenthal MJ. Mitochondrial dysfunction in autism. Semin Pediatr Neurol. 2013;20(3):163\u201375. https:\/\/doi.org\/10.1016\/j.spen.2013.10.008.","journal-title":"Semin Pediatr Neurol"},{"issue":"1","key":"488_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"DL Vargas","year":"2005","unstructured":"Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57(1):67\u201381.","journal-title":"Ann Neurol"},{"issue":"1","key":"488_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ymgme.2009.08.005","volume":"99","author":"O Hasselmann","year":"2010","unstructured":"Hasselmann O, Blau N, Ramaekers VT, Quadros EV, Sequeira JM, Weissert M. Cerebral folate deficiency and CNS inflammatory markers in Alpers disease. Mol Genet Metab. 2010;99(1):58\u201361. https:\/\/doi.org\/10.1016\/j.ymgme.2009.08.005.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"488_CR45","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/j.1471-4159.2008.05479.x","volume":"106","author":"PT Ronaldson","year":"2008","unstructured":"Ronaldson PT, Bendayan R. HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells. J Neurochem. 2008;106(3):1298\u2013313.","journal-title":"J Neurochem"},{"issue":"1","key":"488_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-45878-6","volume":"9","author":"A Omeragic","year":"2019","unstructured":"Omeragic A, Kara-Yacoubian N, Kelschenbach J, Sahin C, Cummins CL, Volsky DJ, et al. Peroxisome proliferator-activated receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model. Sci Rep. 2019;9(1):1\u201312.","journal-title":"Sci Rep"},{"key":"488_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.01346","volume":"10","author":"SF Spampinato","year":"2019","unstructured":"Spampinato SF, Bortolotto V, Canonico PL, Sortino MA, Grilli M. Astrocyte-derived paracrine signals: relevance for neurogenic niche regulation and blood-brain barrier integrity. Front Pharmacol. 2019;10:1\u20139.","journal-title":"Front Pharmacol"},{"key":"488_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2017.00176","volume":"9","author":"SR Subramaniam","year":"2017","unstructured":"Subramaniam SR, Federoff HJ. Targeting microglial activation states as a therapeutic avenue in Parkinson\u2019s disease. Front Aging Neurosci. 2017;9:1\u201318.","journal-title":"Front Aging Neurosci"},{"key":"488_CR49","doi-asserted-by":"crossref","unstructured":"Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. In: Vitamins and Coenzymes Part K. Academic Press; p. 43\u201353. (Methods in Enzymology; vol. 281). 1997. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0076687997810075. Accessed 5 June 2023.","DOI":"10.1016\/S0076-6879(97)81007-5"},{"issue":"5","key":"488_CR50","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41401-020-0487-2","volume":"42","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Chen J, Guo H, Lu-li J, Zhou J, Guo yu X, et al. Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson\u2019s disease model via AMPK activation. Acta Pharmacol Sin. 2021;42(5):665\u201378. https:\/\/doi.org\/10.1038\/s41401-020-0487-2.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"488_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/cpmo.21","volume":"7","author":"PM Quiros","year":"2017","unstructured":"Quiros PM, Goyal A, Jha P, Auwerx J. Analysis of mtDNA\/nDNA ratio in mice. Curr Protoc Mouse Biol. 2017;7(1):47\u201354.","journal-title":"Curr Protoc Mouse Biol"},{"issue":"6","key":"488_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1301\/nr.2004.jun.S3-S12","volume":"62","author":"PJ Stover","year":"2004","unstructured":"Stover PJ. Physiology of folate and vitamin B12 in health and disease. Nutr Rev. 2004;62(6):3\u201312.","journal-title":"Nutr Rev"},{"issue":"10","key":"488_CR53","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jnutbio.2015.05.002","volume":"26","author":"S Thakur","year":"2015","unstructured":"Thakur S, Rahat B, Hamid A, Najar RA, Kaur J. Identification of regulatory mechanisms of intestinal folate transport in condition of folate deficiency. J Nutr Biochem. 2015;26(10):1084\u201394. https:\/\/doi.org\/10.1016\/j.jnutbio.2015.05.002.","journal-title":"J Nutr Biochem"},{"key":"488_CR54","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.biocel.2016.08.040","volume":"79","author":"Y Yang","year":"2016","unstructured":"Yang Y, Li X, Sun Q, He B, Jia Y, Cai D, et al. Folate deprivation induces cell cycle arrest at G0\/G1 phase and apoptosis in hippocampal neuron cells through down-regulation of IGF-1 signaling pathway. Int J Biochem Cell Biol. 2016;79:222\u201330.","journal-title":"Int J Biochem Cell Biol"},{"key":"488_CR55","doi-asserted-by":"publisher","first-page":"137264","DOI":"10.1016\/j.neulet.2023.137264","volume":"807","author":"A Shaikh","year":"2023","unstructured":"Shaikh A, Roy H. Folate deprivation induced neuroinflammation impairs cognition. Neurosci Lett. 2023;807:137264. https:\/\/doi.org\/10.1016\/j.neulet.2023.137264.","journal-title":"Neurosci Lett"},{"key":"488_CR56","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:1\u20139.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"488_CR57","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.1038\/s41598-018-26962-9","volume":"8","author":"XQ Zhou","year":"2018","unstructured":"Zhou XQ, Yao ZW, Peng Y, Mao SS, Xu D, Qin XF, Zhang RJ. PQQ ameliorates D-galactose induced cognitive impairments by reducing glutamate neurotoxicity via the GSK-3\u03b2\/Akt signaling pathway in mouse. Sci Rep. 2018;8(1):8894. https:\/\/doi.org\/10.1038\/s41598-018-26962-9.","journal-title":"Sci Rep"},{"key":"488_CR58","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.intimp.2019.04.040","volume":"72","author":"Z Wang","year":"2019","unstructured":"Wang Z, Han N, Zhao K, Li Y, Chi Y, Wang B. Protective effects of pyrroloquinoline quinone against oxidative stress-induced cellular senescence and inflammation in human renal tubular epithelial cells via Keap1\/Nrf2 signaling pathway. Int Immunopharmacol. 2019;72:445\u201353. https:\/\/doi.org\/10.1016\/j.intimp.2019.04.040.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"488_CR59","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00213-022-06113-9","volume":"239","author":"Y Peng","year":"2022","unstructured":"Peng Y, Xu D, Ding Y, Zhou X. Supplementation of PQQ from pregnancy prevents MK-801-induced schizophrenia-like behaviors in mice. Psychopharmacology. 2022;239(7):2263\u201375. https:\/\/doi.org\/10.1007\/s00213-022-06113-9.","journal-title":"Psychopharmacology"},{"issue":"10","key":"488_CR60","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1021\/acs.chemrestox.0c00083","volume":"33","author":"L Zhao","year":"2020","unstructured":"Zhao L, Sumberaz P. Mitochondrial DNA damage: prevalence, biological consequence, and emerging pathways. Chem Res Toxicol. 2020;33(10):2491\u2013502.","journal-title":"Chem Res Toxicol"},{"key":"488_CR61","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/ijms222413384","volume":"22","author":"P Kowalczyk","year":"2021","unstructured":"Kowalczyk P, Sulejczak D, Kleczkowska P, Bukowska-O\u015bko I, Kucia M, Popiel M, et al. Mitochondrial oxidative stress\u2014a causative factor and therapeutic target in many diseases. Int J Mol Sci. 2021;22:13384.","journal-title":"Int J Mol Sci"},{"issue":"P2","key":"488_CR62","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neubiorev.2014.01.012","volume":"46","author":"D Valenti","year":"2014","unstructured":"Valenti D, de Bari L, De Filippis B, Henrion-Caude A, Vacca RA. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of down syndrome, autism, fragile X and Rett syndrome. Neurosci Biobehav Rev. 2014;46(P2):202\u201317. https:\/\/doi.org\/10.1016\/j.neubiorev.2014.01.012.","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-023-00488-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-023-00488-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-023-00488-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:24:46Z","timestamp":1700439886000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-023-00488-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["488"],"URL":"https:\/\/doi.org\/10.1186\/s12987-023-00488-3","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"5 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}